Implantable ports are designed for patients who require long term access to the central venous system or other internal structures for the administration and/or withdrawal of fluids, including hydration fluids, antibiotics, chemotherapy, analgesics, nutritional therapy and blood products. A catheter is typically inserted to form a path to the vascular system by advancing a distal end of the catheter into a blood vessel while a proximal end is connected to the port that is implanted subcutaneously. The port is generally placed under the skin on the upper part of the chest wall or the upper arm, and allows patients to access the desired body lumen while avoiding repeated needlesticks to the target structure. Power injectable implantable ports offer the additional advantage of providing access for the power injection of contrast agents to enhance imaging, such as Contrast-Enhanced Computer Tomography (CECT) scans, which rely on intravenously administered contrast agents to enhance the visibility of internal structures. The contrast agent is power injected into the blood stream to highlight features that would otherwise be difficult to distinguish from nearby tissues. Thus, power injectable ports provide access for the standard injection and withdrawal of fluids (e.g., for therapeutic purposes) and for power injection of contrast agents to enhance imaging.
Although, it is desirable to use ports which are also suitable for power injection, users must be able to positively identify such ports to ensure they are not accessing a port which is not useable for power injection. The industry has established a “CT” mark, which when viewed under a CT scan, is a standard indication of power injectability. Some existing “CT” identifying technologies known in the field today include a cut-through “CT” design through the port body. The limitation of this design is the space available on the port that would allow for adequate size and visibility of the “CT” lettering. Another disadvantage of cut-through design is that the space could promote tissue ingrowth, which may make it more difficult to remove the port later.
Pad printing the “CT” letters onto the port using radiopaque ink is another existing technology. Radiopaque ink prevents X-rays or similar radiation waves to pass therethrough so that they may be identified in scans. However, the radiopaque ink in these ports is often located on an outer surface of the port, which can be susceptible to damage such as smearing, cracking and fragmenting in the subcutaneous environment, making the marking unreadable. In addition, fragments of ink may migrate, leading to ink integrity issues.
Another CT identifying technology is used in the POWERPORT®, manufactured by Bard Access Systems Inc., Salt Lake City, Utah. The POWERPORT® includes an external metal component with “CT” lettering at the base. However, the “CT” lettering occupies a space on the base of the port where the device labeling is typically placed. Device labeling may include manufacturer and/or lot numbers, which may be helpful in identifying the port. In addition, there is a risk of the external component becoming separated from the device.
The present invention is directed to an implantable port for accessing internal body structures, the port comprises a proximal housing including an opening providing access to an interior of the port and a distal housing adapted for assembly with the proximal housing, the distal housing including a reservoir which, when the distal housing is mated with the proximal housing is in fluid communication with the opening of the proximal housing in combination with a radiopaque element in one of the proximal and distal housings, a shape of the radiopaque element identifying, when imaged, a structural characteristic of the port not otherwise identifiable visually.
The present invention may be further understood with reference to the following description of exemplary embodiments and the related appended drawings, wherein like elements are provided with the same reference numerals. The present invention relates to devices for accessing the vascular system via a catheter and, more specifically, relates to a power-injectable port that may be identified as such after implantation. Those skilled in the art will understand that the ports described herein are generally implanted with an opening through which fluids are to be introduced or withdrawn facing the skin. As used in this application, the term proximal refers to a direction toward the skin while distal refers to a distance deeper into the body.
As shown in
As shown in
As would be understood by those skilled in the art, the radiopaque insert 24 may be embedded within distal housing 12 via an insert molding process in which the radiopaque insert 24 is robotically or hand loaded into a mold cavity between shots. The insert 24 is supported in position in the mold by a series of needle-like core pins and, during injection, these pins are retracted into the mold base as the plastic fills the cavity and encapsulates the insert. Once the insert 24 has been embedded in the distal housing 12, the distal housing 12 is ready to be assembled with the other port components in the same manner for a port without such a radiopaque insert 24. Standard assembly techniques such as ultrasonic welding, snap fit or solvent bond may be utilized as would be understood by those skilled in the art.
As shown in
As described above, the radiopaque insert 36 may be made of any radiopaque material with an identifying mark 46 (e.g., CT) cut-out so that the mark 46 is clearly visible when imaged using any of the known scanning techniques. As the insert 36 is housed between the proximal and distal flanges 38, 42, respectively, the cut-out poses no risk of tissue ingrowth and the risk of the insert 36 becoming detached from the port 30 is also minimized.
In a further embodiment of the present invention, the radiopaque insert 36 may be embedded in either of the proximal and distal flanges 38, 42, respectively using an insert molding process. As described above, the radiopaque insert 36 may be placed into a mold cavity between shots and held in place by a series of needle-like core pins. During injection, these pins are retracted into the mold base as plastic fills the cavity and encapsulates the insert 36. Once the insert 36 has been embedded, the distal housing 32 is ready to be assembled with the other port components including the proximal housing 34 as described above.
In another embodiment of the present invention, as shown in
In a further embodiment, the overmolded insert 54 may be mechanically combined with a port stem and inserted into the mold. Overmolding would then encapsulate and seal the insert 54 into the distal housing 52 while simultaneously binding the stem to the distal housing 52. Such an embodiment provides a radiopaque marker for power injectability while eliminating a separate stem/port assembly step.
In another embodiment of the present invention, shown in
It will be apparent to those skilled in the art that various modifications and variations can be made in the structure and the methodology of the present invention, without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided that they come within the scope of the appended claims and their equivalents.
Number | Name | Date | Kind |
---|---|---|---|
3159175 | Macmillan | Dec 1964 | A |
3477438 | Allen et al. | Nov 1969 | A |
3525357 | Koreski | Aug 1970 | A |
3541438 | Nelsen et al. | Nov 1970 | A |
3669323 | Harker et al. | Jun 1972 | A |
3674183 | Venable et al. | Jul 1972 | A |
3811466 | Ohringer | May 1974 | A |
3853127 | Spademan | Dec 1974 | A |
3955594 | Snow | May 1976 | A |
3971376 | Wichterle | Jul 1976 | A |
4143853 | Abramson | Mar 1979 | A |
4447237 | Frisch et al. | May 1984 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4692146 | Hilger | Sep 1987 | A |
4772270 | Waiita et al. | Sep 1988 | A |
4781680 | Redmond et al. | Nov 1988 | A |
4802885 | Weeks et al. | Feb 1989 | A |
4857053 | Dalton | Aug 1989 | A |
4886501 | Johnston et al. | Dec 1989 | A |
4886502 | Poirier et al. | Dec 1989 | A |
4892518 | Cupp et al. | Jan 1990 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4904241 | Bark | Feb 1990 | A |
4908029 | Bark et al. | Mar 1990 | A |
4929236 | Sampson | May 1990 | A |
5009391 | Steigerwald | Apr 1991 | A |
5009644 | McDonald | Apr 1991 | A |
5045060 | Melsky et al. | Sep 1991 | A |
5053013 | Ensminger et al. | Oct 1991 | A |
5059186 | Yamamoto et al. | Oct 1991 | A |
5069206 | Crosbie | Dec 1991 | A |
5084015 | Moriuchi | Jan 1992 | A |
5092849 | Sampson | Mar 1992 | A |
5129891 | Young | Jul 1992 | A |
5137529 | Watson et al. | Aug 1992 | A |
5147483 | Melsky et al. | Sep 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5180365 | Ensminger et al. | Jan 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5242415 | Kantrowitz et al. | Sep 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5263930 | Ensminger | Nov 1993 | A |
5281199 | Ensminger et al. | Jan 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5318545 | Tucker | Jun 1994 | A |
5350360 | Ensminger et al. | Sep 1994 | A |
5352204 | Ensminger | Oct 1994 | A |
5356381 | Ensminger et al. | Oct 1994 | A |
5387192 | Glantz et al. | Feb 1995 | A |
5396925 | Poli et al. | Mar 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5417656 | Ensminger et al. | May 1995 | A |
5423334 | Jordan | Jun 1995 | A |
5453097 | Paradis | Sep 1995 | A |
5476451 | Ensminger et al. | Dec 1995 | A |
5520643 | Ensminger et al. | May 1996 | A |
5527277 | Ensminger et al. | Jun 1996 | A |
5527278 | Ensminger et al. | Jun 1996 | A |
5531684 | Ensminger et al. | Jul 1996 | A |
5542923 | Ensminger et al. | Aug 1996 | A |
5554117 | Ensminger et al. | Sep 1996 | A |
5556381 | Ensminger et al. | Sep 1996 | A |
5558641 | Glantz et al. | Sep 1996 | A |
5562618 | Cai et al. | Oct 1996 | A |
5607393 | Ensminger et al. | Mar 1997 | A |
5613945 | Cai et al. | Mar 1997 | A |
RE35601 | Eckenhoff | Sep 1997 | E |
5662616 | Bousquet | Sep 1997 | A |
5707357 | Mikhail et al. | Jan 1998 | A |
5741228 | Lambrecht et al. | Apr 1998 | A |
5755780 | Finch et al. | May 1998 | A |
5792104 | Speckman et al. | Aug 1998 | A |
5792123 | Ensminger | Aug 1998 | A |
5797886 | Roth et al. | Aug 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5848989 | Villani | Dec 1998 | A |
5879322 | Lattin et al. | Mar 1999 | A |
5882341 | Bousquet | Mar 1999 | A |
5897528 | Schultz | Apr 1999 | A |
5906596 | Tallarida | May 1999 | A |
5911706 | Estabrook et al. | Jun 1999 | A |
5941856 | Kovacs et al. | Aug 1999 | A |
5944688 | Lois | Aug 1999 | A |
5944698 | Fischer et al. | Aug 1999 | A |
5954687 | Baudino | Sep 1999 | A |
5954691 | Prosl | Sep 1999 | A |
5961497 | Larkin | Oct 1999 | A |
5989216 | Johnson et al. | Nov 1999 | A |
6056717 | Finch et al. | May 2000 | A |
6086555 | Eliasen et al. | Jul 2000 | A |
6099508 | Bousquet | Aug 2000 | A |
6152909 | Bagaoisan et al. | Nov 2000 | A |
6210366 | Sanfilippo | Apr 2001 | B1 |
6287293 | Jones et al. | Sep 2001 | B1 |
6306124 | Jones et al. | Oct 2001 | B1 |
6527754 | Tallarida et al. | Mar 2003 | B1 |
6592571 | Verbeek et al. | Jul 2003 | B1 |
6610031 | Chin | Aug 2003 | B1 |
6726063 | Stull et al. | Apr 2004 | B2 |
6962577 | Tallarida et al. | Nov 2005 | B2 |
7033339 | Lynn | Apr 2006 | B1 |
20010016717 | Haarala et al. | Aug 2001 | A1 |
20010056266 | Tallarida et al. | Dec 2001 | A1 |
20020013557 | Sherry | Jan 2002 | A1 |
20020121530 | Socier | Sep 2002 | A1 |
20030109856 | Sherry | Jun 2003 | A1 |
20030141477 | Miller | Jul 2003 | A1 |
20030216694 | Tollini | Nov 2003 | A1 |
20040133173 | Edoga et al. | Jul 2004 | A1 |
20040186444 | Daly et al. | Sep 2004 | A1 |
20050010176 | Dikeman et al. | Jan 2005 | A1 |
20050027234 | Waggoner et al. | Feb 2005 | A1 |
20050027261 | Weaver et al. | Feb 2005 | A1 |
20050080401 | Peavey | Apr 2005 | A1 |
20060178647 | Stats | Aug 2006 | A1 |
20060224129 | Beasley et al. | Oct 2006 | A1 |
20060247584 | Sheetz et al. | Nov 2006 | A1 |
20070078391 | Wortley et al. | Apr 2007 | A1 |
20070100302 | DiCarlo et al. | May 2007 | A1 |
20070233017 | Zinn et al. | Oct 2007 | A1 |
Number | Date | Country |
---|---|---|
0128525 | Dec 1984 | EP |
0343910 | Nov 1989 | EP |
0366814 | May 1990 | EP |
2508008 | Dec 1982 | FR |
2809315 | Nov 2001 | FR |
0966137 | Aug 1964 | GB |
2102398 | Feb 1983 | GB |
WO-9206732 | Apr 1992 | WO |
WO-9405351 | Mar 1994 | WO |
WO-9516480 | Jun 1995 | WO |
WO-9701370 | Jan 1997 | WO |
WO-9723255 | Jul 1997 | WO |
WO-9726931 | Jul 1997 | WO |
WO-9818506 | Aug 1997 | WO |
WO-0012171 | Mar 2000 | WO |
WO-0016844 | Mar 2000 | WO |
WO-0033901 | Jun 2000 | WO |
WO-0160444 | Aug 2001 | WO |
WO-03084832 | Oct 2003 | WO |
WO-2005068009 | Jul 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20100063451 A1 | Mar 2010 | US |